Theravance Biopharma Inc (0TB) — Defensive Interval Ratio
Theravance Biopharma Inc (0TB) has a Defensive Interval Ratio of 1690 days as of September 2025. Defensive assets of €173.17 Million (cash €-, short-term investments €154.91 Million, receivables €18.27 Million) cover 1690 days of daily cash needs of €102.48K/day. See Theravance Biopharma Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Theravance Biopharma Inc Defensive Interval Ratio (2014–2024)
This chart shows how Theravance Biopharma Inc's Defensive Interval Ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 1690 days, meaning defensive assets of €173.17 Million can fund 1690 days of operations without new revenue. See Theravance Biopharma Inc balance sheet quality to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Theravance Biopharma Inc (2014–2024)
The table below presents the year-by-year Defensive Interval Ratio for Theravance Biopharma Inc from 2014 to 2024, covering 11 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Theravance Biopharma Inc (0TB) market capitalisation.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 785 days | €68.99 Million | €87.90K/day | €- | €50.55 Million | ▼ -399 days |
| 2023 | 1184 days | €80.36 Million | €67.85K/day | €- | €62.88 Million | ▲ +598 days |
| 2022 | 586 days | €46.10 Million | €78.67K/day | €- | €29.31 Million | ▼ -22 days |
| 2021 | 608 days | €97.57 Million | €160.51K/day | €- | €83.51 Million | ▼ -64 days |
| 2020 | 672 days | €227.34 Million | €338.55K/day | €- | €211.47 Million | ▼ -222 days |
| 2019 | 893 days | €273.34 Million | €306.04K/day | €- | €222.77 Million | ▲ +362 days |
| 2018 | 531 days | €143.35 Million | €270.01K/day | €- | €127.25 Million | ▼ -1038 days |
| 2017 | 1569 days | €268.95 Million | €171.38K/day | €- | €259.59 Million | ▲ +339 days |
| 2016 | 1231 days | €166.11 Million | €134.98K/day | €- | €156.39 Million | ▲ +516 days |
| 2015 | 715 days | €96.88 Million | €135.53K/day | €- | €59.73 Million | ▼ -767 days |
| 2014 | 1482 days | €167.53 Million | €113.03K/day | €- | €165.40 Million | — |